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Edited by Robert BaroukiAbstract We investigated the signaling pathway that leads
to the expression of heme oxygenase-1 (HO-1) in murine
macrophages in response to 15-deoxy-D12,14-prostaglandin J2
(15dPGJ2). 15dPGJ2 caused dose- and time-dependent activa-
tion of Rac1, followed by a transient increase in reactive oxygen
species (ROS) via NADPH oxidase, which leads to downstream
activation of p38 kinase. Inhibition of 15dPGJ2-dependent HO-1
expression signiﬁcantly attenuated suppression by 15dPGJ2 of
LPS-induced iNOS expression and subsequent production of
nitric oxide (NO). Our ﬁndings strongly suggest that 15dPGJ2
exerts its anti-inﬂammatory activity through the Rac1-NADPH
oxidase-ROS-p38 signaling to the up-regulation of HO-1 in an
in vitro inﬂammation model.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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15-Deoxy-D12,14-prostaglandin J2 (15dPGJ2) is an immuno-
regulatory lipid metabolite derived from prostaglandin D2
(PGD2) dehydration in vivo, which is abundantly produced
by mast cells, dendritic cells, and alveolar macrophages [1–3].
As a ligand for the peroxisome proliferators activated recep-
tor-c (PPAR-c), 15dPGJ2 exhibits anti-inﬂammatory eﬀects
that modulate the vascular inﬂammation and the atherosclero-
sis process [4,5]. However, other accumulating data suggest
that the PPAR-c-independent mechanism may account for
the major anti-inﬂammatory action of 15dPGJ2. For example,
15dPGJ2 repress several pro-inﬂammatory genes, including
inducible nitric oxide synthase (iNOS) and tumor necrosis fac-
tor-a (TNF-a) genes in macrophages derived from PPAR-c-
deﬁcient embryonic stem cells [6,7]. 15dPGJ2 also performs
its anti-inﬂammatory activity through direct inhibition of*Corresponding author. Address: Department of Biochemistry and
Research Institute of Life Sciences, College of Natural Sciences,
Kangwon National University, 192-1 Hyoja-2-dong, Chuncheon 200-
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doi:10.1016/j.febslet.2008.02.012signaling steps leading to nuclear factor-kappa B (NF-kB) acti-
vation [8,9], eventually down-regulating expression of pro-
inﬂammatory cytokines and immune mediators.
Heme oxygenase-1 (HO-1) is a microsomal enzyme, catalyz-
ing the breakdown of heme into equimolar amounts of carbon
monoxide (CO), biliverdin, and free iron using molecular oxy-
gen and reducing equivalents from NADPH:cytochrome P450
reductase [10,11]. HO-1 contributes to the host defense reac-
tion against oxidative injury through the antioxidant activities
of biliverdin and its metabolite, bilirubin, as well as the anti-
inﬂammatory action of CO [12,13]. A growing body of evi-
dence revealed that 15dPGJ2 induces HO-1 expression through
mechanisms independent of PPAR-c activation and dependent
on cellular redox state in various cell types [14,15]. Further-
more, the anti-inﬂammatory actions of 15dPGJ2 are function-
ally correlated with the induction of HO-1 expression [16],
suggesting an important role of HO-1 in PPAR-c-independent
mechanism for anti-inﬂammatory action of 15dPGJ2. Despite
these reports, the detailed signaling pathway by which
15dPGJ2 mediates induction of HO-1 expression remains lar-
gely unknown.
Regarding the signaling mechanisms of HO-1 induction, sev-
eral studies have suggested involvement of reactive oxygen spe-
cies (ROS) [17,18]. ROS, such as hydrogen peroxide (H2O2),
superoxide (O2) and hydroxyl radical (OH
), are important reg-
ulator of various biological processes, including cell prolifera-
tion, apoptosis, and inﬂammation. An important ROS source
within phagocytic cells is the NADPH oxidase, which consists
of two transmembrane ﬂavocytochrome b components
(gp91phox and p22phox) and the three cytosolic components
(p47phox, p67phox, and p40phox), and Rac1, a member of the
Rho family GTPases, plays a central role in activating this
complex [19]. We here demonstrate that 15dPGJ2 exerts its
in vitro anti-inﬂammatory activity through the Rac1-NADPH
oxidase-ROS-p38 signaling to the up-regulation of HO-1.2. Materials and methods
2.1. Materials
15dPGJ2 was obtained from Biomol (Plymouth Meeting, PA). Lipo-
polysaccharide (LPS), diphenylenepropodiumiodide (DPI), apocynin,
N-acetylcysteine (NAC), reduced glutathione (GSH) and buthionine
sulfoximine (BSO) were purchased from Sigma Chemical Co. (St.
Louis, MI, USA). The following were obtained from Calbiochemblished by Elsevier B.V. All rights reserved.
862 H.-Y. Hong et al. / FEBS Letters 582 (2008) 861–868(La Jolla, CA): U0126, a MAPK kinase inhibitor; PD169316, a p38
inhibitor; SP600125, a JNK inhibitor. Small interfering RNAs for con-
trol, mouse p47phox and mouse p67phox were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA).2.2. DNA constructs
pEXV, pEXV-Rac1N17, pEXV-Cdc42N17, pEXV-RhoAN19, and
pEXV-Rac1V12 were a kind gift from Dr. Alan Hall (Department of
Biochemistry and Molecular Biology, University College London,
London, UK). The plasmid pHO-1-Luc was provided by Dr. Norbert
Leitinger (Department of Vascular Biology and Thrombosis Research,
University of Vienna, Vienna, Austria) and contains a 4.9-kb human
promoter upstream of a luciferase gene as described previously [20].
The mouse iNOS promoter-luciferase plasmid DNA, piNOS-Luc,
was gift from Dr. Young-Myeong Kim (Kangwon National Univer-
sity, Chuncheon, Korea).2.3. Cell culture and generation of stable cell lines
RAW264.7, a mouse macrophage cell line, obtained from American
Type Culture Collection (Manassas, VA), was cultured in Dulbeccos
modiﬁed Eagles medium supplemented with 2 mM L-glutamine, 10%
heat-inactivated fetal bovine serum, 100 U/ml penicillin, and 100 lg/
ml streptomycin. Cells were co-transfected with pcDNA and pEXV,
or pEXV-Cdc42N17, encoding a dominant negative Cdc42 mutant,
or pEXV-Rac1N17, encoding a dominant negative Rac1 mutant, or
pEXV-RhoAN19, encoding a dominant negative RhoA mutant, using
the FuGENE 6 (Roche, Mannheim, Germany) transfection method.
One day after transfection, cells were selected for G418 (Invitrogen,
Carlsbad, CA) resistance. After two weeks of selection, G418-resistant
clones were populated and analyzed using anti-c-myc mouse Ab (9E10;
Santa Cruz Biotechnology).
2.4. DNA transfection and luciferase assay
The RAW264.7 cells were transfected using FuGENE 6. To control
for variation in transfection eﬃciency, all clones were co-transfected
with 0.2 lg of CMV-b-GAL, a eukaryotic expression vector in which
Escherichia coli b-galactosidase (Lac Z) structural gene is under the
transcriptional control of the CMV promoter. Cytosolic extracts were
prepared 24 h after transfection by using a luciferase cell lysis buﬀer
(Promega, Madison, WI). Luciferase reporter activity was assessed
on a luminometer with a luciferase assay system (Promega) according
to the manufacturers protocol. Transfection experiments were per-
formed in triplicate with two independently isolated sets, and the
results were averaged.
2.5. Rac1 activity assay
Rac1 activity was measured as described previously [21] using a
GST-p21-activated serine/threonine protein kinase (PAK)-PAK-bind-
ing domain (PBD) fusion protein that binds GTP-bound, acti-
vated Rac1. Brieﬂy, the fusion protein was expressed in E. coli BL21
transformed with pGEX-4T3 plasmid by incubation with isopropyl-
1-thio-b-D-galactopyranoside and then puriﬁed by column chromatog-
raphy using glutathione-Sepharose-4B beads. RAW264.7 cells were
serum-starved (0.1% FBS) for 4 h, stimulated with 1 lM 15dPGJ2
for the indicated times or with the indicated concentrations of
15dPGJ2 for 5 min, and then lysed in lysis buﬀer (150 mM NaCl,
20 mM Tris–Cl (pH 7.4), 2.5 mM sodium pyrophosphate, 1% Triton
X-100, 100 mM NaF, 1 mM PMSF, and 1 mM Na2VO3). The lysates
were centrifuged for 15 min at 12000 · g, after which the supernatant
was incubated for 30 min at 4 C with GST-(PAK)-PBD fusion protein
freshly coupled to glutathione-agarose beads. The proteins that were
complexed to the beads were recovered and subjected to 15% SDS–
PAGE. The resolved proteins were probed with anti-Rac1 mouse Ab
(BD Biosciences, San Jose, CA). The detected proteins were visualized
using HRP-conjugated donkey anti-mouse IgG Ab and an ECL detec-
tion kit (Pharmacia Biotech, Uppsala, Sweden).
2.6. Immunoblot analysis
Cytosolic extracts were obtained in 1% Triton X-100 lysis buﬀer
(50 mM Tris–Cl, pH 8.0, 150 mM sodium chloride, 1 mM EDTA,
1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM sodium ortho-
vanadate, 1 mM b-glycerophosphate, 1 lg/ml leupeptin, and 1 mM
phenylmethylsulfonyl ﬂuoride). Western blotting was performed usinganti-HO-1 (H105; Santa Cruz Biotechnology), anti-iNOS (54; Trans-
duction Laboratories, Lexington, KY), anti-phospho-p38 (3D7; Cell
Signaling Technology, Beverly, MA), and anti-b-actin (AC-15; Sigma)
antibodies. Protein samples were heated at 95 C for 5 min and ana-
lyzed by SDS–PAGE. Immunoblot signals were developed by Super
Signal Ultra chemiluminescence detection reagents (Pierce Biotechnol-
ogy, Rockford, IL).
2.7. Measurement of intracellular ROS
For analysis of intracellular ROS, the redox-sensitive ﬂuorescent
probe DCFH-DA was used, as previously described [22]. Cells were
incubated with 5 lM DCFH-DA for 30 min at 37 C. The harvested
cells were immediately analyzed by a ﬂow cytometry.
2.8. Indirect immunoﬂuorescence
RAW264.7 cells were plated at 1 · 105 cells onto 18 mm glass cover-
slips 24 h prior to treatments. The cells were serum-starved for 4 h in
serum-free culture medium, and incubated with 1 lM 15dPGJ2 for var-
ious time periods. The coverslips were ﬁxed in cold 3.5% paraformal-
dehyde for 5 min, permeabilized in cold methanol for 2 min and
incubated for 5 min in 50 mM glycine. The p67phox and Rac1 were
then detected by incubation with anti-Rac1 rabbit polyclonal antibody
(23A8; Upstate, VA) and anti-p47phox rabbit polyclonal antibody (H-
195; Santa Cruz Biotechnology) for 2 h at room temperature. After
washing in phosphate-buﬀered saline (PBS), the coverslips were incu-
bated for 1 h at room temperature with ﬂuorescein isothiocyanate
(FITC) conjugated goat anti-mouse IgG and rhodamine (TRITC) con-
jugated goat anti-rabbit IgG secondary antibodies (Molecular Probes).
Stained cells were washed, mounted in medium containing 4,6-diami-
no-2-phenylindole (DAPI) (h-1200; Vector Laboratories, Burlingame,
CA) and examined using a Olympus Fluoview-FV300 confocal micro-
scope.
2.9. Nitrite assay
The nitrite level is generally accepted as indicative of NO produc-
tion. Accumulated nitrite ðNO2 Þ in cell culture supernatants was deter-
mined using a colorimetric assay based on the Griess reaction [23]. The
supernatants (100 ll) were reacted with a 100 ll Griess reagent (6 mg/
ml) at room temperature for 10 min, and then NO2 concentration was
determined by measuring absorbance at 540 nm. A standard curve was
constructed using known concentrations of sodium nitrite.2.10. Statistical analysis
All data presented are expressed as means ± S.D., and represent
three independent experiments. Statistical analyses were assessed by
unpaired Students t-test. Results were considered signiﬁcant at
P < 0.05.3. Results and discussion
3.1. Induction of HO-1 expression by 15dPGJ2 is dependent on
Rac1 activation
A previous study has implicated the role of reactive oxygen
species (ROS) in up-regulation of HO-1 by 15dPGJ2 in human
lymphocytes [14]. In phagocytes, an importance source of ROS
is NADPH oxidase, and Rac1, a member of Rho family GTP-
ases, plays a central role in activating this complex. To assess
whether Rac1 is involved in the 15dPGJ2 signaling pathway
leading to HO-1 gene expression, we generated cell lines stably
expressing a dominant negative mutant of Cdc42, Rac1, or
RhoA (Cdc42N17, Rac1N17, or RhoAN19, respectively) in
RAW 264.7 cells. Treatment of RAW264.7pEXV control cells
with 15dPGJ2 induced HO-1 expression (Fig. 1A, upper panel)
and HO-1 promoter activity (Fig. 1A, lower panel) in a dose-
dependent manner. This eﬀect was evident at concentrations of
15dPGJ2 as low as 0.1 lM. Using 1 lM of 15dPGJ2 for vary-
ing time periods, induction of HO-1 expression (Fig. 1B, upper
panel) and HO-1 promoter activity (Fig. 1B, lower panel)
Fig. 1. Role of Rac1 in 15dPGJ2-induced HO-1 expression in murine macrophages. RAW264.7 cells were transiently transfected with HO-1
promoter-responsive luciferase reporter gene (pHO-1-Luc). The transfectants were treated with the indicated concentrations of 15dPGJ2 for 24 h (A)
or with 1 lM 15dPGJ2 for the indicated times (B). Cell lysates were fractionated on 12% SDS–PAGE to determine the level of HO-1 and b-actin
protein expression (upper panels of A and B), and the luciferase activity of HO-1 promoter was measured by luminometer as described in Section 2
(lower panels of A and B). (C) RAW264.7pEXV, RAW264.7pEXV-Cdc42N17, RAW264.7pEXV-Rac1 N17 and RAW264.7pEXV-RhoAN19 cells, which were
transiently transfected with the pHO-1-Luc, incubated without or with 1 lM 15dPGJ2 for 24 h. HO-1 and b-actin protein levels (upper panel) and the
luciferase activity of HO-1 promoter (lower panel) were analyzed as described in A and B. In low panels of A, B and C, bars depict the means ± S.D.
of three independent experiments. The serum-starved RAW264.7 cells were treated with 1 lM 15dPGJ2 for the indicated times (D) or with the
indicated concentrations for 5 min (E). The cell lysates were incubated with GST-PAK-PBD that was coupled to glutathione-agarose beads. Bound
Rac-GTPase was eluted and resolved by 15% SDS–PAGE. Rac-GTPase activity was detected using an anti-Rac1 antibody as a probe. As a control of
protein quantity, the total amount of Rac1 was also determined by Western blotting analysis.
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bly, both RAW264.7pEXV-Cdc42N17 and RAW264.7pEXV-RhoAN19
cells treated with 15dPGJ2 stimulated HO-1 protein expression
(Fig. 1C, upper panel) and HO-1 promoter activity (Fig. 1C,
lower panel) as eﬃciently as the control cells, whereas this
stimulating eﬀect was remarkably reduced in cells expressing
Rac1N17, suggesting that Rac1 is a key mediator in 15dPGJ2
signaling to HO-1 expression. Consistent with the proposed
mediatory role of Rac1 in 15dPGJ2 signaling, a signiﬁcant
stimulation of cellular Rac1 activity was induced, which was
followed by the addition of 15dPGJ2 in time- (Fig. 1D) and
dose- (Fig. 1E) dependent manner.3.2. 15dPGJ2 induces HO-1 expression via a Rac1-NADPH
oxidase-ROS pathway
It has been known that NADPH oxidase activation requires
stimulus-induced translocation of the cytosolic regulatory pro-
teins, including p47phox and p67phox, from cytosol to the mem-
brane-associated ﬂavocytochrome b558 [24], and Rac1 plays a
central role in mediating reactive oxygen species (ROS) pro-
duction derived from NADPH oxidase in many phagocytic
cells. To determine whether p47phox is involved in Rac1-depen-
dent 15dPGJ2 signaling, we ﬁrst analyzed the time-course
subcellular localization of Rac1 and p47phox on 15dPGJ2 treat-
ment. Endogenous Rac1 and p47phox detected in RAW264.7
Fig. 2. Role of Rac1 in 15dPGJ2-induced ROS production. (A) Cells were treated with 1 lM 15dPGJ2 for the indicated times. Cells were then ﬁxed,
and the immunoﬂuorescence staining with antibodies against Rac1 (green) and p47phox (red) was performed, and visualized with confocal microscopy
as described in Section 2. (B) RAW264.7pEXV and RAW264.7pEXV-Rac1N17 cells were pretreated with the H2O2-sensitive ﬂuorescence dye DCFH-DA
for 20 min, and then stimulated with 1 lM 15dPGJ2 for 10 min. DCF ﬂuorescence was quantiﬁed as described in Section 2.
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(Fig. 2A). However, 15dPGJ2 treatment resulted in dramatic
rearrangements of the endogenous Rac1 and p47phox, leading
to predominant accumulation on the plasma membrane within
5 min (Fig. 2A). We next examined whether both Rac1 and
NADPH oxidase are involved in 15dPGJ2-evoked ROS gener-
ation. To do this, RAW264.7pEXV or RAW264.7pEXV-Rac1 N17
cells were treated with 15dPGJ2, and changes in the intracellu-
lar levels of ROS were monitored using the H2O2-sensitive
ﬂuorescence dye DCFH-DA. As shown in Fig. 2B, 15dPGJ2-
induced increases in DCF ﬂuorescence was completely abol-
ished in RAW264.7pEXV-Rac1N17 cells. These results suggest
that 15dPGJ2 produces intracellular ROS via Rac1/NADPH
oxidase in murine macrophages.
Next, we examined any role of ROS for the up-regulation of
HO-1 in response to 15dPGJ2. As shown in Fig. 3, two thiol
antioxidants N-acetylcysteine (NAC) and glutathione (GSH)
completely inhibited 15dPGJ2-induced HO-1 expression
(upper panel) and HO-1 promoter activity (lower panel). Wes-
tern blot analysis showed that transfection of siRNA speciﬁc
for p47phox dose-dependently suppressed the expression of
HO-1 induced by15dPGJ2 (Fig. 3B). Furthermore, Rac1V12,
a constitutively active mutant of Rac1, stimulated HO-1 pro-
moter activity, and this eﬀect was signiﬁcantly attenuated by
siRNAs speciﬁc for p47phox and p67phox, two cytosolic compo-
nents of NADPH oxidase (Fig. 3C). Collectively, 15dPGJ2 in-
duces HO-1 expression in the non-stimulated RAW264.7
macrophage cells through the mediation of Rac1 followed by
NADPH oxidase/ROS signaling in sequence.
3.3. p38 kinase acts downstream of ROS in 15dPGJ2 signaling to
HO-1 expression
Recent studies have shown that signaling pathways involv-
ing mitogen-activated protein kinases (MAPKs) are ultimatelyresponsible for on HO-1 induction by stress stimuli [14,25]. So,
we tested the eﬀects of three MAPK inhibitors on up-regula-
tion of HO-1 expression by 15dPGJ2 in macrophages. The
15dPGJ2-mediated increase in HO-1 protein level was dose-
dependently blocked by PD169316, a speciﬁc inhibitor of
p38, whereas similar concentrations of U0126, a speciﬁc inhib-
itor of MAP/extracellular-signal regulated kinase1/2 (ERK1/2)
kinase (MEK), or SP600125, a speciﬁc inhibitor of c-Jun NH2-
terminal kinase1/2 (JNK1/2), had no signiﬁcant eﬀect
(Fig. 4A). Consistent with this result, 15dPGJ2-induced HO-
1 promoter activation was also dose-dependently abolished
in cells transfected with dominant-negative mutant of p38
(DNp38) (Fig. 4B), suggesting that p38 has a speciﬁc role in
15dPGJ2 signaling to HO-1 expression. To determine whether
Rac1 activation is situated up- or downstream of p38 in the
15dPGJ2 signaling pathway, we examined the phosphorylation
of p38 after 15dPGJ2 stimulation in RAW264.7
pEXV and
RAW264.7pEXV-Rac1N17 cells. We found that 15dPGJ2 time-
dependently increased phosphorylation of p38 in RAW-
264.7pEXV cells whereas this eﬀect was completely blocked
by stable expression of Rac1N17 (Fig. 4C). In addition,
15dPGJ2-induced transactivating potential of GAL4-ATF2
was signiﬁcantly decreased by siRNAs speciﬁc for p47phox
and p67phox (Fig. 4D). It thus appears that 15dPGJ2 stimulates
the production of ROS via Rac1-NADPH oxidase-linked sig-
naling cascade, this leads to p38 kinase activation and subse-
quently to HO-1 expression.
3.4. Suppression by 15dPGJ2 of LPS-stimulated NO production
is mediated through the Rac1-dependent signaling to up-
regulation of HO-1
Lipopolysaccharide (LPS) is a bacterial endotoxin, which
promotes the secretion of pro-inﬂammatory cytokines, includ-
ing inducible nitric oxide synthase (iNOS) and provides an
Fig. 3. Involvement of Rac1-NADPH oxidase-ROS cascade in 15dPGJ2 – induced HO-1 expression. (A) RAW264.7 cells, which were transfected
with pHO-1-Luc, were preincubated with 20 lM BSO, 5 mM NAC or 2 mM GSH for 30 min and then treated or not with 1 lM 15dPGJ2 for 24 h.
Cell lysates were fractionated on 12% SDS–PAGE to determine the level of HO-1 and b-actin protein expression (upper panel), and the luciferase
activity of HO-1 promoter was measured by luminometer as described in Section 2 (lower panel). Bars depict the means ± S.D. of three independent
experiments. (B) RAW264.7 cells, which were transfected with control or indicated concentrations of p47phox siRNA oligonucleotides, were
incubated with1 lM 15dPGJ2 for 24 h. HO-1 and b-actin protein expression levels were determined by Western blotting. (C) pEXV or pEXV-
Rac1V12 was co-transfected with pHO-1-Luc and control, p47phox or p67phox siRNA oligonucleotide. Transfectants were incubated for 24 h prior to
luciferase assay. Bars depict the means ± S.D. of three independent experiments.
Fig. 4. Involvement of p38 as a downstream mediator of ROS in 15dPGJ2 signaling. (A) Cells were pretreated with indicated concentrations of
U0126, PD169316 or SP600125 for 30 min before challenge with 1 lM 15dPGJ2 for 24 h. HO-1 and b-actin protein levels were determined by
Western blotting analysis. (B) RAW264.7 cells, which were co-transfected with pHO-1-Luc and the indicated quantities of DNp38, were treated or
not with 1 lM 15dPGJ2 for 24 h prior to luciferase assay. Bars depict the means ± S.D. of three independent experiments. (C) RAW264.7
pEXV and
RAW264.7pEXV-Rac1N17 cells were incubated with 1 lM 15dPGJ2 for the indicated times. The extent of phosphorylation of p38 was determined by
Western blotting analysis. (D) RAW264.7 cells, which were co-transfected with pFR-Luc and GAL4-ATF2, were re-transfected with control, p47phox
or p67phox siRNA oligonucleotide. Transfectants were incubated with 1 lM 15dPGJ2 for 24 h prior to luciferase assay. Bars depict the means ± S.D.
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RAW264.7 cells with 15dPGJ2 suppressed LPS-induced iNOSexpression (Fig. 5, upper panel) and production of nitric oxide
(NO) (Fig. 5A, lower panel) in a dose-dependent manner. The
Fig. 5. Rac1 is required for the suppression by 15dPGJ2 of LPS-induced NO production. (A) Cells were pretreated with the indicated concentrations
of 15dPGJ2 for 3 h before challenge with LPS (1 lg/ml) for 24 h. Whole lysates were analyzed for iNOS expression by Western blotting (upper panel).
The nitrites accumulation in culture medium was determined with Griess reagent (lower panel). (B) RAW264.7 cells were transfected with murine
iNOS promoter. The cells were incubated without or with 1 lM 15dPGJ2 for 3 h in the absence or presence of ZnPP (1 lM) or CuPP (1 lM),
followed by treatment without or with 1 lg/ml LPS for additional 24 h. Whole lysates were analyzed for iNOS, b-actin and HO-1 expression by
Western blotting (upper panel). Luciferase activities were muasured as described in Section 2 (lower panel). Bars depict the means ± S.D. of three
independent experiments. (C) RAW264.7pEXV (V) and RAW264.7pEXV-Rac1 N17 (N) cells were preincubated with 1 lM 15dPGJ2 for 3 h prior to LPS
(1 lg/ml) for 24 h. Whole lysates were analyzed for iNOS expression by Western blotting (upper panel). The nitrites accumulation in culture medium
was determined with Griess reagent (lower panel). Bars depict the means ± S.D. of three independent experiments. *P < 0.05.
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15dPGJ2 was tested using a speciﬁc HO competitive inhibitor,
zinc protoporphyrin IX (ZnPP), or an inactive compound,
copper protoporphyrin IX (CuPP). Pretreatment with ZnPP
gave rise to suppression in the inhibition by 15dPGJ2 of
LPS-stimulated iNOS expression (Fig. 5B, upper panel) and
iNOS promoter activity (Fig. 5B, lower panel), whereas pre-
treatment with CuPP had no eﬀect on the inhibition by
15dPGJ2 of LPS-stimulated iNOS expression and iNOS pro-
moter activity, consistent with several recent reports that
HO-1 negatively regulates the LPS-induced iNOS expression
[26,27]. We ﬁnally determined whether Rac1 mediates the
inhibitory eﬀect of 15dPGJ2 on LPS-induced iNOS expression
and NO production. As shown in Fig. 5C, 15dPGJ2-mediatedsuppression of LPS-stimulated iNOS expression (upper panel)
and NO production (lower panel) was signiﬁcantly attenu-
ated in RAW264.7pEXV-Rac1N17 cells compared with the
RAW264.7pEXV cells, suggesting that Rac1 is involved in
15dPGJ2-mediated suppression of LPS-induced NO produc-
tion in murine macrophages.
HO-1 is believed to beneﬁcially play a cytoprotective role in
a variety of pathological models such as inﬂammation. Carbon
monoxide, a key product of HO, inhibits iNOS mRNA induc-
tion in cytokine-stimulated intestinal epithelial cells [12]. Bili-
rubin, a potent antioxidant, is produced from biliverdin,
markedly inhibits iNOS expression and NO production in
lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage
cells. However, despite its role as a potent anti-inﬂammatory
H.-Y. Hong et al. / FEBS Letters 582 (2008) 861–868 867mediator, the intracellular signaling pathway leading to the
induction of HO-1 expression is not well understood. The pres-
ent study provides the ﬁrst evidence of the pivotal roles played
by Rac1 and NADPH oxidase in the anti-inﬂammatory signal-
ing by which 15dPGJ2 induces the expression of HO-1 in
RAW264.7 macrophages.
LPS is a bacterial endotoxin, which promotes the secretion
of pro-inﬂammatory cytokines and related molecules, includ-
ing iNOS in many cell types. Lanone et al. [28] reported that
NADPH oxidase activity is required for LPS-induced iNOS
expression in RAW264.7 macrophages, and this ﬁnding is
opposite to the role of NADPH oxidase showed in the present
study. Many studies, however, relied on the results obtained
with DPI or apocyanin at micromolar or millimolar concentra-
tions. Besides acting as an NADPH oxidase-like ﬂavoenzyme
inhibitor, DPI has been also reported to be a potent inhibitor
of iNOS with an IC50 of 50 nM [29]. In line with this, Heumu¨l-
ler et al. [30] reported that apocynin is not an inhibitor of vas-
cular NADPH oxidase. We also observed that DPI at
submicromolar concentrations completely blocked LPS-in-
duced NO production, whereas DPI at the same condition
had a little eﬀect to inhibits the LPS-induced iNOS expression
(see Fig. 6A, which is published in supporting information). In
addition, LPS-induced iNOS expression and NO production
were little aﬀected by two thiol antioxidants NAC and GSH,
and exogenous hydrogen peroxide failed to induces iNOS
expression and subsequent NO production (see Fig. 6B, C
and D, which is published in supporting information). From
these ﬁndings, we carefully imply that ROS is a minor contrib-
utor in LPS-evoked intracellular signaling to inﬂammatory
response, and the major eﬀect of DPI on suppression of
LPS-induced NO production is primarily due to the inhibition
of iNOS activity rather than the inhibition of NADPH oxi-
dase. Furthermore, support for this conception comes from
the observation that p47phox siRNA transfection inhibited
the induction of anti-inﬂammatory enzyme, HO-1 in response
to 15dPGJ2.
In conclusion, our data provide, for the ﬁrst time, evidence
that 15dPGJ2 induces HO-1 expression in murine RAW264.7
macrophages, which is mediated via Rac1/NADPH oxidase-
dependent generation of ROS leading to the activation of
p38 mitogen-activated protein (MAP) kinase. Furthermore,
our results suggest that HO-1 up-regulation via the Rac1/
NADPH oxidase/ROS/p38 cascade is critical for the anti-
inﬂammatory action of 15dPGJ2.
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